483 related articles for article (PubMed ID: 23682925)
1. Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.
Curtin NJ
Br J Pharmacol; 2013 Aug; 169(8):1745-65. PubMed ID: 23682925
[TBL] [Abstract][Full Text] [Related]
2. DNA repair dysregulation from cancer driver to therapeutic target.
Curtin NJ
Nat Rev Cancer; 2012 Dec; 12(12):801-17. PubMed ID: 23175119
[TBL] [Abstract][Full Text] [Related]
3. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against Cancer.
Fernandes SG; Shah P; Khattar E
Anticancer Agents Med Chem; 2022; 22(3):469-484. PubMed ID: 34102988
[TBL] [Abstract][Full Text] [Related]
5. Targeting the DNA damage response in oncology: past, present and future perspectives.
Basu B; Yap TA; Molife LR; de Bono JS
Curr Opin Oncol; 2012 May; 24(3):316-24. PubMed ID: 22476188
[TBL] [Abstract][Full Text] [Related]
6. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
7. Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.
Darzynkiewicz Z; Traganos F; Wlodkowic D
Eur J Pharmacol; 2009 Dec; 625(1-3):143-50. PubMed ID: 19836377
[TBL] [Abstract][Full Text] [Related]
8. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
[TBL] [Abstract][Full Text] [Related]
9. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B
DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757
[TBL] [Abstract][Full Text] [Related]
10. Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.
Rozpędek W; Pytel D; Nowak-Zduńczyk A; Lewko D; Wojtczak R; Diehl JA; Majsterek I
Curr Med Chem; 2019; 26(8):1425-1445. PubMed ID: 29345572
[TBL] [Abstract][Full Text] [Related]
11. Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer.
Ng YB; Akincilar SC
Curr Opin Pharmacol; 2024 Jun; 76():102460. PubMed ID: 38776747
[TBL] [Abstract][Full Text] [Related]
12. Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.
Davalli P; Marverti G; Lauriola A; D'Arca D
Oxid Med Cell Longev; 2018; 2018():2389523. PubMed ID: 29770165
[TBL] [Abstract][Full Text] [Related]
13. The DNA Damaging Revolution: PARP Inhibitors and Beyond.
Yap TA; Plummer R; Azad NS; Helleday T
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():185-195. PubMed ID: 31099635
[TBL] [Abstract][Full Text] [Related]
14. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs, DNA Damage Response, and Cancer Treatment.
He M; Zhou W; Li C; Guo M
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973455
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.
Solier S; Zhang YW; Ballestrero A; Pommier Y; Zoppoli G
Curr Cancer Drug Targets; 2012 May; 12(4):356-71. PubMed ID: 22385513
[TBL] [Abstract][Full Text] [Related]
17. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
Goldstein M; Kastan MB
Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
[TBL] [Abstract][Full Text] [Related]
18. Targeting the microRNA-regulating DNA damage/repair pathways in cancer.
Bottai G; Pasculli B; Calin GA; Santarpia L
Expert Opin Biol Ther; 2014 Nov; 14(11):1667-83. PubMed ID: 25190496
[TBL] [Abstract][Full Text] [Related]
19. DNA damage response and prostate cancer: defects, regulation and therapeutic implications.
Karanika S; Karantanos T; Li L; Corn PG; Thompson TC
Oncogene; 2015 May; 34(22):2815-22. PubMed ID: 25132269
[TBL] [Abstract][Full Text] [Related]
20. DNA damage response inhibitors: An avenue for TNBC treatment.
Jin J; Tao Z; Cao J; Li T; Hu X
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188521. PubMed ID: 33556453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]